1. Working in partnership to deliver better Epilepsy
services
31/01/13
Manchester
Matt Eddleston and Kate Trenam - Healthcare Partnership Managers

2. Agenda
A brief look at UCB
Objective of this session
The HPM Role and 2013 Objectives
Data tools for commissioning services
Data examples and case study
Working together – How and Who’s who?
Next steps

3. UCB: A patient-centric biopharma leader
Focusing on severe diseases in
Immunology and the Central Nervous System
2011 revenue: €3.2 billion
More than 8,000 employees
globally
Operations in more than 40
countries
R&D Spend: 24% of revenue
Listed on Euronext
Stephanie, living with rheumatoid arthritis
3
Mar 2012: UK/12MIS0027

4. UCB - Our Global Presence
4
Mar 2012: UK/12MIS0027

5. UCB’s vision and strategies
5
Mar 2012: UK/12MIS0027

6. UCB in the UK
6
Carrie, living with Crohn’s disease
Mar 2012: UK/12MIS0027

7. UCB in the UK
Our UK site houses the immunology
research hub and the head office for the
UK commercial organisation
UK research hub focuses on research for
conditions such as rheumatoid
arthritis, epilepsy, lupus and osteoporosis
Employing approx 600 staff in the UK;
400 in R&D
Recently invested £25 million in the ‘UCB
Biologics R&D Centre’; state-of-the-art
laboratory
7
Mar 2012: UK/12MIS0027

8. UCB in the UK
A top 5 investor in UK Pharmaceutical
Research & Development (R&D):
investing >£230 million in 2010*
Providing over 50 approved medicines
within the UK
Supporting ~30 UK PhD's at any one
time
Spending more than €500,000 annually
on PhD support
* Based upon data in the 2010 BIS R&D Scoreboard (BIS = Department for Business, 8
Innovation & Skills Mar 2012: UK/12MIS0027

9. Summary
Against a backdrop of dramatic job cuts & reductions spend from
many pharma companies; UCB has a more positive story to tell
We want to stay at the cutting edge; as a result we invest
heavily in R&D
• In 2011, R&D accounted for 24% of revenue
• 40% of our research spend is in the UK and we continue to
invest in new facilities and research
Industry and academic and voluntary sector partnerships
are essential for UCB
9
Mar 2012: UK/12MIS0027

10. Objective
Provide clear understanding of HPM role
Provide a clear understanding of the data tools and how we use
them
Provide a clear understanding of Commissioning Advocate
Objectives
Identify opportunities for working together
Agree next steps

11. UCB Healthcare Partnership Managers
The NHS is changing
The industry model is changing
Focus on the whole health economy not just on the benefits of the
drugs we produce
• Government
• National Commissioning
• Local Commissioning
HPM
• Trust Managers
• Pharmacy
• Clinicians

12. Creating Value in the NHS
Reducing Costs
VALUE
Increasing Improving Patient
Efficiency Experience

13. HPM objectives 2013
Work in Partnership with the NHS to create value in Epilepsy
What is UCB’s offering?
Facilitate stakeholder meetings
Provide benchmarking data
Share best practice
Help define the problems and solutions
Assist in commissioning through clear business plans
Implement and promote the new services

14. The Commissioning Cycle
NEEDS ANALYSIS
NEEDS ANALYSIS SERVICE DEVELOPMENT APPROVAL IMPLEMENATION
JSNA
National Priorities What are we Launch and PR
Trust Priorities changing?
QIPP
CQUIN
Patient Pathway
NHS Data Best practice
Launch meetings
Facilitation PR Documentation
Impact review
Business Case
Development
Data
Modelling

15. Data tools
Hospital Episodes Statistics Pathway Simulation Tool
NHS data NHS data
ICD 10 Codes applied to all QOF or HES
procedures Assesses the impact of
NHS find it difficult to community services
manipulate Simulat8
Quantis database
South Yorkshire Epilepsy NE Lincs Neurology Project
Project

16. South Yorkshire Epilepsy Project - Context
• Epilepsy services are not equitable across the region
• Sheffield does not have the capacity to continue with the same number of
referrals to their tertiary clinics
• This in turn applies pressure on their general neurology clinics
• Doncaster and Rotherham per population do not have equitable services to
those in Sheffield and Barnsley
STAKEHOLDERS
Clinical lead engaged and motivated
CCG Commissioner engaged and motivated
GP’s engaged

17. Project Objective
Deliver equitable and sustainable Epilepsy services in
Sheffield, Barnsley, Doncaster and Rotherham
• Improve services in Doncaster and Rotherham to relieve
pressure on Sheffield

18. Return for the patient and the NHS
NHS Patient
Reduction in referral costs – Reduction in variation
tertiary and general neurology Right treatment right time
Reinvestment into community Care closer to home
services Better all round management
Reduction in variation = better QOL
Good model of partnership
working in new NHS
Return for UCB?
HES data

19. Epilepsy pathway simulation tool
The Pathway tool ‘Simul8’ uses either HES or QOF data to
map the patient pathway from diagnosis through to
secondary care
It then looks at the impact of introducing community
services in the form of specialist nurses and dedicated
telephone services
The results form the basis of a written report that we will
pull together looking at, amongst other things, patient
through put and of course cost
The next slide is a screen shot of the tool

20. Epilepsy pathway simulation tool

21. Epilepsy pathway simulation tool
Typical report

22. Epilepsy Action and UCB working in partnership to
deliver better services - Opportunities
An alliance to reduce inequalities in epilepsy healthcare
The NHS are looking for complete solutions
HPM team and Commissioning Advocates:
• Same objectives
• Compliment each others work
• Data provision and funding
• Best practice and expertise
• Driving Epilepsy on the agenda
• Referrals
• Local meetings

23. Who’s Who?
Harrogate
1) Manchester
2) Stockport Chester le Street
Scarborough
Sheffield
West
Midlands
Coventry
Dorking
London

24. Contact Details
matt.eddleston@ucb.com - 07770 960 168
• Lancashire, Merseyside, Greater Manchester, Yorkshire, Lincolnshire
Kate.trenham@ucb.com - 07976 600 594
• Sussex, Surrey, Hampshire, IOW, Gloucestershire, Somerset, Devon, C
ornwall, Dorset
vincenzo.straccia@ucb.com - 07841 959 039
• Norfolk, Suffolk, Greater
London, Essex, Kent, Bedfordshire, Cambridgeshire, Northamptonshire
suzanne.fletcher@ucb.com - 07713 074 083
• Oxfordshire, Thames Valley, Staffordshire, E&W
Midlands, Leicester, Derbyshire, Nottinghamshire
david.walter@ucb.com – 07768 107 597
• National Healthcare Partnership Manager
• Flip chart Advocate details
• ADD GUY A

25. Next Steps
HPM to contact equivalent commissioning advocate
Agree local meeting
Discuss local objectives
Agree plan for working together
• Are there existing projects where we could work
together?
• Where could we target together?

26. Questions?